| Style | Citing Format |
|---|---|
| MLA | Noursina A, Safari F. "Enhancing Colorectal Cancer Screening Specificity by Integrating Fecal Microrna Signature With Fecal Immunochemical Test and Fecal Occult Blood Test." Gastroenterology, vol. 166, no. 2, 2024, pp. 358-. |
| APA | Noursina A, Safari F (2024). Enhancing Colorectal Cancer Screening Specificity by Integrating Fecal Microrna Signature With Fecal Immunochemical Test and Fecal Occult Blood Test. Gastroenterology, 166(2), 358-. |
| Chicago | Noursina A, Safari F. "Enhancing Colorectal Cancer Screening Specificity by Integrating Fecal Microrna Signature With Fecal Immunochemical Test and Fecal Occult Blood Test." Gastroenterology 166, no. 2 (2024): 358-. |
| Harvard | Noursina A, Safari F (2024) 'Enhancing Colorectal Cancer Screening Specificity by Integrating Fecal Microrna Signature With Fecal Immunochemical Test and Fecal Occult Blood Test', Gastroenterology, 166(2), pp. 358-. |
| Vancouver | Noursina A, Safari F. Enhancing Colorectal Cancer Screening Specificity by Integrating Fecal Microrna Signature With Fecal Immunochemical Test and Fecal Occult Blood Test. Gastroenterology. 2024;166(2):358-. |
| BibTex | @article{ author = {Noursina A and Safari F}, title = {Enhancing Colorectal Cancer Screening Specificity by Integrating Fecal Microrna Signature With Fecal Immunochemical Test and Fecal Occult Blood Test}, journal = {Gastroenterology}, volume = {166}, number = {2}, pages = {358-}, year = {2024} } |
| RIS | TY - JOUR AU - Noursina A AU - Safari F TI - Enhancing Colorectal Cancer Screening Specificity by Integrating Fecal Microrna Signature With Fecal Immunochemical Test and Fecal Occult Blood Test JO - Gastroenterology VL - 166 IS - 2 SP - 358 EP - PY - 2024 ER - |